These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1124148)

  • 1. [Trial treatment of diabetic retinopathy by inhibition of pituitary somatotropin secretion with MAP].
    Bruni B; Bruni-Bocher K; Della Valle A; Gamba S
    Minerva Med; 1975 Mar; 66(21):1001-23. PubMed ID: 1124148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum growth hormone levels and the response of diabetic retinopathy to pituitary ablation.
    Wright AD; Kohner EM; Oakley NW; Hartog M; Joplin GF; Fraser TR
    Br Med J; 1969 May; 2(5653):346-8. PubMed ID: 5768460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial gamma irradiation by 198Au of the pituitary in diabetic retinopathy. Selective growth hormone blockade and ocular results.
    Schaub C; Szikla G; Drouin P; Bleut-Pajot MT; Mejean L; Debry G; Talairach J
    J Neurosurg; 1977 Jun; 46(6):703-16. PubMed ID: 323427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secretion of GH and diabetic retinopathy].
    Greco AV; Ricci B; Ghirlanda G; Fedeli G; Altomonte L; Rebuzzi A
    Minerva Med; 1976 Sep; 67(45):2902-18. PubMed ID: 967359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysectomy in diabetic retinopathy. The relationship between the degree of pituitary ablation and ocular response.
    Adams DA; Rand RW; Roth NH; Dashe AM; Gipstein RM; Heuser G
    Diabetes; 1974 Aug; 23(8):698-707. PubMed ID: 4604549
    [No Abstract]   [Full Text] [Related]  

  • 6. Computer analysis of ocular results following selective blockade of growth-hormone in diabetic retinopathy. A collaborative study.
    Schaub C; Boujard O; Brouard N; Drouin P; Le Devehat C; Lemoine A; Mejean L; Mounier F; Regnault F; Saudax A
    Metab Ophthalmol; 1984-1985; 8(1):35-42. PubMed ID: 6394947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Arch Ophthalmol; 1988 Sep; 106(9):1242-6. PubMed ID: 3046587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of medroxyprogesterone on plasma somatotropin (GH) levels in 14 patients with acromegaly].
    Tourniaire J; Pousset G
    Ann Endocrinol (Paris); 1973; 34(2):222-4. PubMed ID: 4745280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of pituitary deficiency by hypoglycemia-induced growth hormone secretion in hypophysectomized diabetics].
    Teuscher A; Escher F; Zahnd G
    Schweiz Med Wochenschr; 1969 Jul; 99(31):1110-4. PubMed ID: 5406976
    [No Abstract]   [Full Text] [Related]  

  • 12. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.
    Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W
    Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Somatotropic hormone, diabetes and diabetic angiopathy].
    Dobrev DG
    Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C; Koerner F
    Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of diabetic retinopathy with somatostatin analogues].
    Lang GE
    Ophthalmologe; 2004 Mar; 101(3):290-3. PubMed ID: 15007609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ophthalmologic indications and results of stereo-GIHF in diabetic retinopathy. 2].
    Debry G; Schaub C; Drouin P; Szikla ; Saudax E; Boujard O; Talairach J
    Neurochirurgie; 1977 Jul; 23(2):97-109. PubMed ID: 562480
    [No Abstract]   [Full Text] [Related]  

  • 17. Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
    Kohner EM; Stratton IM; Aldington SJ; Turner RC; Matthews DR
    Diabetologia; 1999 Sep; 42(9):1107-12. PubMed ID: 10447523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of diabetic retinopathy and treatment.
    Hollows FC; Beaumont P
    Trans Ophthalmol Soc N Z; 1973; 25():50-5. PubMed ID: 4519230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic retinopathy: different risk factors for exudates and haemorrhages.
    Dowd TC; Howard-Williams J; Thursfield V; Bron AJ; Hockaday TD; Mann JI
    Int Ophthalmol; 1986 Apr; 9(1):11-5. PubMed ID: 3721707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
    Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.